Evanson Financial LLC bought a new position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 9,396 shares of the company's stock, valued at approximately $1,378,000.
A number of other institutional investors have also recently added to or reduced their stakes in PG. Carson Advisory Inc. increased its holdings in Procter & Gamble by 0.5% in the 4th quarter. Carson Advisory Inc. now owns 12,124 shares of the company's stock valued at $1,738,000 after purchasing an additional 65 shares during the last quarter. Trilogy Capital Inc. lifted its stake in Procter & Gamble by 1.1% during the fourth quarter. Trilogy Capital Inc. now owns 6,289 shares of the company's stock worth $901,000 after purchasing an additional 67 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its position in shares of Procter & Gamble by 1.8% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company's stock worth $549,000 after buying an additional 67 shares during the period. Lorne Steinberg Wealth Management Inc. boosted its position in shares of Procter & Gamble by 2.7% during the fourth quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company's stock worth $376,000 after buying an additional 68 shares during the period. Finally, Grant Street Asset Management Inc. grew its stake in shares of Procter & Gamble by 2.7% in the fourth quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company's stock valued at $376,000 after buying an additional 69 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Stock Performance
NYSE:PG opened at $145.88 on Friday. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.68 and a quick ratio of 0.47. The firm has a market capitalization of $339.09 billion, a PE ratio of 22.04, a price-to-earnings-growth ratio of 4.52 and a beta of 0.39. The business's fifty day moving average price is $147.86 and its 200 day moving average price is $148.98.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.41 by $0.02. The business had revenue of $21.20 billion for the quarter, compared to the consensus estimate of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The business's revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, August 17th. Investors of record on Friday, July 24th will be paid a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 3.0%. The ex-dividend date is Friday, July 24th. Procter & Gamble's dividend payout ratio (DPR) is currently 65.71%.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on PG. HSBC restated a "hold" rating and set a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. JPMorgan Chase & Co. cut their price target on shares of Procter & Gamble from $164.00 to $162.00 and set an "overweight" rating on the stock in a research note on Thursday, July 16th. Wells Fargo & Company increased their price target on shares of Procter & Gamble from $158.00 to $164.00 and gave the stock an "overweight" rating in a research report on Monday, April 27th. Argus cut shares of Procter & Gamble from a "buy" rating to a "hold" rating in a report on Friday. Finally, Evercore set a $162.00 target price on shares of Procter & Gamble in a research note on Monday, April 27th. Thirteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $161.52.
Check Out Our Latest Analysis on Procter & Gamble
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: PG’s $3.8 billion acquisition of Thorne would expand its presence in vitamins, supplements and wellness products, providing a potential avenue for longer-term growth beyond its traditional consumer-staples categories. Procter & Gamble making $3.8 billion acquisition of supplements company Thorne
- Positive Sentiment: PureCycle Technologies reported that its first commercial recycled-resin deliveries to PG have begun, with select Downy detergent caps now in production. The development supports PG’s sustainability efforts and could help secure recycled materials for packaging. PureCycle Technologies Reports Second Quarter 2026 Results
- Neutral Sentiment: PG continues to be highlighted as a defensive consumer-staples and dividend stock amid market volatility. However, elevated Treasury yields may make dividend-paying equities somewhat less attractive relative to bonds. 5 Solid Dividend Stocks to Buy in August
- Negative Sentiment: Argus downgraded PG from “buy” to “hold.” The change removes a positive analyst catalyst and likely reflects concerns about valuation, modest recent sales growth and limited near-term upside.
- Negative Sentiment: Discussion surrounding the Thorne acquisition has focused on product quality and safety concerns. Although these are not confirmed problems, such concerns could increase reputational and integration risks for PG as it enters the supplements market. Procter & Gamble Buys Supplement Brand Thorne — People Have Thoughts
Procter & Gamble Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Recommended Stories
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.